Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management
To access this article, please choose from the options below
PII: S0165-5728(11)00227-X
doi:10.1016/j.jneuroim.2011.08.010
© 2011 Elsevier B.V. All rights reserved.
